OpenAI revealed Astra, its next major model, by publishing ten proofs of problems open for a decade or more. The total ...

Learn how to play slots online, see RTP explained, bankroll management tips and common mistakes to avoid. Get started with popular slots today.

GOOSE produces blueprints for custom-built disordered proteins that are then created in genetically engineered cells.

Alphabet's (GOOG +1.85%)(GOOGL +2.20%) second-quarter report this week buried the figure under two louder storylines -- a $99 billion paper gain on its equity stakes, and another increase in capital ...

Holding an international ETF in a taxable account costs more than most investors realize, and the culprit is a tax quirk buried in how foreign dividends get classified. The case for moving that ...

Conservative legislators in at least eight states want to require schools to teach students that earning at least a high school diploma, securing a full-time job, and getting married before having ...

New research has discovered that the molecular machines responsible for copying our DNA have a surprising hidden talent: an ability to create entirely new and highly sophisticated DNA sequences from ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...